These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12196748)

  • 21. Familial pityriasis rubra pilaris: case report and review.
    Mercer JM; Pushpanthan C; Anandakrishnan C; Landells ID
    J Cutan Med Surg; 2013; 17(4):226-32. PubMed ID: 23815954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult onset pityriasis rubra pilaris.
    Sehgal VN; Srivastava G; Dogra S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection.
    Betto P; Vassilopoulou A; Colombari R; Veller-Fornasa C
    G Ital Dermatol Venereol; 2008 Aug; 143(4):271-3. PubMed ID: 18833084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute postinfectious pityriasis rubra pilaris: a superantigen-mediated dermatosis].
    Ferrándiz-Pulido C; Bartralot R; Bassas P; Bodet D; Repiso T; Aparicio G; Mollet J; Serra M; García-Patos V
    Actas Dermosifiliogr; 2009 Oct; 100(8):706-9. PubMed ID: 19775549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy.
    Müller H; Gattringer C; Zelger B; Höpfl R; Eisendle K
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S65-70. PubMed ID: 19119128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pityriasis rubra pilaris: algorithms for diagnosis and treatment.
    Roenneberg S; Biedermann T
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):889-898. PubMed ID: 29247481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pityriasis rubra pilaris, type IV.
    Bragg J; Witkiewicz A; Orlow SJ; Schaffer JV
    Dermatol Online J; 2005 Dec; 11(4):14. PubMed ID: 16403386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pityriasis rubra pilaris: a case series of 28 patients.
    Kromer C; Lippert U; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):569-579. PubMed ID: 33021474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Biologics in Pityriasis Rubra Pilaris Refractory to First-Line Systemic Therapy: A Systematic Review [Formula: see text].
    Naidoo A; Sibbald C; Fleming PJ; Piguet V
    J Cutan Med Surg; 2020; 24(1):73-78. PubMed ID: 31691587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual cluster of circumscribed juvenile pityriasis rubra pilaris cases.
    Martin KL; Holland KE; Lyon V; Chiu YE
    Pediatr Dermatol; 2014; 31(2):138-45. PubMed ID: 24456130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of pityriasis rubra pilaris-induced cicatricial ectropion with systemic low-dose methotrexate.
    Durairaj VD; Horsley MB
    Am J Ophthalmol; 2007 Apr; 143(4):709-10. PubMed ID: 17386290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alitretinoin (9-cis retinoic acid) is effective against pityriasis rubra pilaris: a retrospective clinical study.
    Amann PM; Susic M; Glüder F; Berger H; Krapf W; Löffler H
    Acta Derm Venereol; 2015 Mar; 95(3):329-31. PubMed ID: 24995552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis rubra pilaris. Further observations of systemic retinoid therapy.
    Borok M; Lowe NJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):792-5. PubMed ID: 2347965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute pityriasis rubra pilaris in the child. Apropos of 4 cases].
    Larrègue M; Champion R; Bressieux JM; Laidet B; Lorette G
    Ann Dermatol Venereol; 1983; 110(3):221-8. PubMed ID: 6614736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pityriasis rubra pilaris].
    Quenan S; Laffitte E
    Rev Med Suisse; 2016 Mar; 12(512):653-7. PubMed ID: 27172696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pityriasis rubra pilaris].
    Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis rubra pilaris--a retrospective single center analysis over eight years.
    Gemmeke A; Schönlebe J; Koch A; Wollina U
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):439-44. PubMed ID: 20202046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of pityriasis rubra pilaris associated with membranous nephropathy.
    Lin CY; Maurice PD; Cross NB
    Australas J Dermatol; 2013 Feb; 54(1):e1-3. PubMed ID: 23373888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.